Onesource Specialty Pharma

Onesource Specialty Pharma Intangibles/Assets

The Intangible Assets to Total Assets Ratio of Onesource Specialty Pharma (ONESOURCE.NS) as of Oct 30, 2026 is 20.54 %. In the previous year, Intangible Assets to Total Assets Ratio was 24.87 % — a change of -17.42% (lower).

Intangibles/Assets

20.54 %

YoY

-17.42%

Last updated:

Intangible Assets to Total Assets Ratio of Onesource Specialty Pharma is 2025 20.54 % . Intangible Assets to Total Assets Ratio of Onesource Specialty Pharma was 2024 24.87 % . It decreases by -17.42% lower compared to the previous year.

The Onesource Specialty Pharma Intangibles/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangibles/Assets
Date
Intangibles/Assets
Jan 1, 2023
16.81 INR
Jan 1, 2024
24.87 INR
Jan 1, 2025
20.54 INR
The Onesource Specialty Pharma Intangibles/Assets history
YEARIntangibles/AssetsYoY
20.54 %-17.42%
24.87 %+47.93%
16.81 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Onesource Specialty Pharma Stock analysis

What does Onesource Specialty Pharma do? Onesource Specialty Pharma Ltd operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO) within the Life Sciences Tools & Services industry. Based in Bangalore, Karnataka, the India-based company provides vertically integrated biopharma services, focusing on the development and manufacture of complex biologics, biosimilars, and vaccines. Its core offerings include prefilled syringes with or without safety devices, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoinjectors. The firm supports the development of complex biologics such as microbial and mammalian cell line biopharmaceuticals, cell and gene therapy, and ribonucleic acid (RNA) products. The company generates revenue by catering to a variety of capsule shapes and sizes through its integrated services. These services encompass formulations ranging from traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and su. By providing comprehensive biologics solutions, the firm serves clients requiring advanced manufacturing capabilities for diverse pharmaceutical delivery systems and therapeutic modalities. Onesource Specialty Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Onesource Specialty Pharma stock

Intangible Assets to Total Assets Ratio of Onesource Specialty Pharma is 20.54 % in 2025.

Intangible Assets to Total Assets Ratio of Onesource Specialty Pharma changed from 24.87 % to 20.54 %, representing a -17.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets to Total Assets Ratio Onesource Specialty Pharma since 2006 – with annual values, charts, and detailed analysis.

The Intangibles/Assets ratio shows the proportion of total assets that are intangible. High ratios are common in technology and pharmaceutical companies.

Intangible Assets to Total Assets Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets to Total Assets Ratio's Onesource Specialty Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Onesource Specialty Pharma

All Key Metrics — Onesource Specialty Pharma